KDM4B is frequently overexpressed in various cancers, where it promotes gene expression under hypoxic conditions and enhances metabolic activity in castration-resistant prostate cancer (CRPC) by functioning as a coactivator of c-Myc [80]. This evidence concerns the gene KDM4B and cancer.